Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

3(60.0%)

N/A

2(40.0%)

5Total

Phase 2(3)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06961578Not ApplicableRecruiting

SCORE Study: Comparing Surgery and Rigid Collar Treatment for Odontoid Fractures in Adults Over 70

Role: collaborator

NCT07113587Phase 2Completed

Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis

Role: collaborator

NCT07113574Phase 2Completed

Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis

Role: collaborator

NCT07056023Recruiting

Multicenter Trial on Surgical Outcome and Quality of Life in Juxta-medullary Tumors

Role: collaborator

NCT03968250Not ApplicableCompleted

CBT on Fatigue in Survivors of Hodgkin Lymphoma

Role: collaborator

NCT01947621Unknown

International Takotsubo Registry (InterTAK Registry)

Role: collaborator

NCT00331669Phase 2Unknown

Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia

Role: collaborator

All 7 trials loaded